TY  - RPRT
TI  - In Silico Molecular-Based Rationale for SARS-CoV-2 Spike Circulating Mutations Able to Escape Bamlanivimab and Etesevimab Monoclonal Antibodies
AU  - Laurini, E.
AU  - Marson, D.
AU  - Aulic, S.
AU  - Fermeglia, A.
AU  - PRICL, S.
PY  - 2021
DO  - 10.1101/2021.05.18.444605
UR  - https://www.biorxiv.org/content/10.1101/2021.05.18.444605v1
ID  - 10.1101/2021.05.18.444605
ER  -